Rybelsus 7mg Tablet 10's

Rybelsus 7mg Tablet contains Semaglutide 7mg, an oral medication used to improve blood sugar control in adults with type 2 diabetes.

Benefits

This medicine helps manage blood sugar levels by stimulating insulin release when needed, reducing glucose production by the liver, and slowing down food digestion. Proper blood sugar control is crucial for preventing serious diabetes complications. Additionally, Rybelsus 7mg Tablet can reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who are at high risk for these events.

Uses and Indications

• To improve blood sugar (glucose) in adults with type 2 diabetes, as an adjunct to diet and exercise.
• To reduce the risk of major cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with type 2 diabetes mellitus who are at high risk for these events.

The Rybelsus 7mg Tablet contains:

• Semaglutide 7mg (active ingredient).
• Inactive ingredients: Salcaprozate sodium (SNAC), Povidone K90, Microcrystalline cellulose, Magnesium stearate.

Dosage and Administration

1. Take one Rybelsus 7mg Tablet once daily.
2. Swallow the tablet whole with no more than 4 ounces (120 mL) of plain water. Do not cut, crush, or chew the tablet.
3. Take it first thing in the morning on an empty stomach, at least 30 minutes before the first food, beverage, or any other oral medications of the day.
4. If a dose is missed, skip the missed dose and take the next dose the following day. Do not take two doses to make up for a missed dose.

Storage and Disposal

• Store at room temperature, between 68°F–77°F (20°C–25°C).
• Keep the tablets in their original child-resistant bottle or blister packaging to protect them from moisture and light.
• Do not transfer tablets to a pill organizer or other containers.
• Keep out of reach of children.

Precautions and Safety

• Rybelsus is not for use in patients with type 1 diabetes mellitus or diabetic ketoacidosis.
• Do not use if you or your family has a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2).
• Exercise caution if you have a history of pancreatitis, as Rybelsus has not been studied in these patients.
• Avoid drinking alcohol, as it can affect your blood sugar levels.
• Inform your doctor about all other medications and supplements you are taking to avoid potential interactions.
• Contact your doctor immediately if you experience severe stomach pain or signs of an allergic reaction (e.g., anaphylaxis, angioedema).
• Pregnant or breastfeeding women should consult their doctor before using this medicine; Rybelsus should not be used during pregnancy or breastfeeding.
• Monitor renal function if severe gastrointestinal reactions occur.

Side Effects and Risks

• Common side effects include nausea, abdominal pain, diarrhea, decreased appetite, vomiting, and constipation. These usually improve as your body adjusts to the medicine.
• Rybelsus can lead to low blood sugar levels (hypoglycemia), especially if taken with other diabetes medicines like insulin or sulfonylureas. It is important to have regular meals and carry a fast-acting source of glucose.
• Possible serious side effects include inflammation of your pancreas (pancreatitis), changes in vision, dehydration leading to kidney problems, severe stomach problems, serious allergic reactions, and gallbladder problems.

Disclaimer

Use this medicine only under the prescription and guidance of a qualified doctor or pharmacist.